Key result
Smoking cessation reduced CRP levels over time, but levels remained elevated up to 5 years post-cessation, with lifetime pack-years showing an independent dose relationship with CRP.
Why the study?
Does smoking cessation and lifetime smoking exposure affect C-reactive protein levels in adults without CHD?
Cross-Sectional (n=4,072)
Yes
Does smoking cessation and lifetime smoking exposure affect C-reactive protein levels in adults without CHD?
Lifetime smoking exposure continues to impact CRP levels post-cessation, suggesting CRP elevation is mediated by secondary mechanisms like tissue damage rather than direct cigarette smoke effects.
Answers are grounded in this paper and cite their sources.
Persistent CRP elevation post-cessation may confound CV risk assessment in former smokers; hypothesis-generating for lasting inflammatory effects of smoking history.
C-reactive protein (CRP) levels predict coronary heart disease (CHD) risk. Levels are raised among smokers, but the effect of smoking cessation is unclear. Exposure to secondhand smoke (SHS) may be a confounder. Lifetime smoking exposure may have a dose effect on CRP among smokers, but it is unclear if this persists after cessation. We analyzed cross-sectional data on 4,072 adults recruited to a Scotland-wide population health survey who did not have CHD and were not on nicotine replacement therapy. CRP fell with time from cessation but was still raised up to 5 years after adjustment for case-mix (p<.001). SHS exposure was greater among ex-smokers than never-smokers (median cotinine 0.5 ng/ml vs. 0.4 ng/ml, p<.001) but did not explain the difference. Among smokers, there was a dose relationship between pack years and CRP on both univariate, F(4,1279) = 31.841, p<.001, and multivariate, F(4,1085) = 3.499, p = .008, analysis. Among ex-smokers there was also a dose relationship between pack-years and CRP, F(4,751) = 14.108, p<.001, which was independent of time from cessation and case-mix, F(4,466) = 3.744, p = .005. That CRP does not fall to normal levels immediately and that lifetime smoking exposure continues to impact on CRP levels post cessation suggest that CRP is not raised as a direct effect of cigarette smoke but rather via a secondary mechanism, such as tissue damage causing an inflammatory stimulus. Our results reinforce the need to encourage smoking cessation as early as possible.
No takes yet. Share an insight, caveat, or question.
Hastie et al. (2008) conducted a cross-sectional in Smoking and C-reactive protein levels (n=4,072). Smoking cessation and lifetime smoking exposure vs. Never-smokers and current smokers was evaluated on C-reactive protein (CRP) levels (p=<.001). Smoking cessation reduced CRP levels over time, but levels remained elevated up to 5 years post-cessation, with lifetime pack-years showing an independent dose relationship with CRP.
Synapse has enriched 10 related papers. Consider them for comparative context: